Product Name:methyl 5-amino-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate

IUPAC Name:methyl 5-amino-4-fluoro-1-methyl-1H-1,3-benzodiazole-6-carboxylate

CAS:918321-20-7
Molecular Formula:C10H10FN3O2
Purity:95%
Catalog Number:CM128230
Molecular Weight:223.21

Packing Unit Available Stock Price($) Quantity
CM128230-5g in stock Ŕƅƻ
CM128230-25g in stock ŭșƏ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:918321-20-7
Molecular Formula:C10H10FN3O2
Melting Point:-
Smiles Code:O=C(C1=C(N)C(F)=C2N=CN(C)C2=C1)OC
Density:
Catalog Number:CM128230
Molecular Weight:223.21
Boiling Point:
MDL No:MFCD26127252
Storage:Keep in dark place, store at 2-8°C.

Category Infos

Benzimidazoles
Benzimidazole is a benzo derivative of imidazole. It is a kind of bicyclic aromatic organic compounds, which is formed by fusing a six-membered benzene ring and five-membered imidazole at positions 4 and 5 of imidazole ring. It is an important pharmacophore of many biologically active heterocyclic compounds with various pharmacological activities. Benzimidazoles and their derivatives have developed into dynamic heterocyclic systems due to their potency in a variety of biologically active compounds such as anticancer, bactericidal and antiviral drugs. Benzimidazoles are a class of therapeutic motifs with broad relevance in medicinal chemistry.

Column Infos

Encorafenib plus Binimetinib
U.S. FDA approved Pfizer's BRAFTOVI® (Encorafenib) + MEKTOVI® (Binimetinib) for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation. The FDA's approval is based on data from the ongoing Phase 2 PHAROS clinical trial. Encorafenib is an oral small molecule BRAF kinase inhibitor, and Binimetinib is an oral small molecule MEK inhibitor targeting key proteins in the MAPK signaling pathway (RAS-RAF-MEK-ERK).
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products